STRATEC SE
Designs and manufactures automated solutions for diagnostics and life science OEM partners.
SBS | F
Overview
Corporate Details
- ISIN(s):
- DE000STRA555 (+1 more)
- LEI:
- 529900ZZJWANAFSPGV30
- Country:
- Germany
- Address:
- Gewerbestraße 37, 75217 Birkenfeld
- Website:
- https://www.stratec.com/home
- Sector:
- Manufacturing
Description
STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-10-27 07:23 |
STRATEC reports on first nine months of 2016 (news with additional features)
|
English | 18.2 KB | ||
| 2016-10-27 00:00 |
Conference Call Quarterly Statement 9M|2016
|
English | 864.3 KB | ||
| 2016-10-27 00:00 |
Q3 statement / Q3 financial report 2016
|
German | 780.4 KB | ||
| 2016-08-31 20:05 |
STRATEC Biomedical AG: Release according to Article 26a of the WpHG [the German…
|
English | 4.0 KB | ||
| 2016-07-29 17:56 |
STRATEC Biomedical AG: Release according to Article 26a of the WpHG [the German…
|
English | 3.9 KB | ||
| 2016-07-21 07:45 |
STRATEC - Results for 1st Half of 2016 and new Financial Guidance
|
English | 17.8 KB | ||
| 2016-07-21 00:00 |
Half-yearly financial report 2016
|
German | 293.8 KB | ||
| 2016-07-21 00:00 |
Conference Call Half-yearly Financial Report H1|2016
|
English | 1.3 MB | ||
| 2016-07-13 20:16 | English | 1.9 KB | |||
| 2016-07-01 11:38 |
STRATEC completes acquisition of Sony DADC BioSciences
|
English | 8.0 KB | ||
| 2016-06-30 20:04 |
STRATEC Biomedical AG: Release according to Article 26a of the WpHG [the German…
|
English | 3.9 KB | ||
| 2016-06-09 16:24 |
STRATEC Annual General Meeting approves record dividend
|
English | 6.6 KB | ||
| 2016-06-08 14:37 |
STRATEC signed an agreement to acquire the BioSciences business of Sony DADC
|
English | 10.9 KB | ||
| 2016-06-08 14:36 |
STRATEC signs agreement to acquire the BioSciences business of Sony DADC
|
English | 5.8 KB | ||
| 2016-04-29 15:15 |
STRATEC Biomedical AG: Bekanntmachung der Einberufung zur Hauptversammlung am 0…
|
German | 34.2 KB |
Automate Your Workflow. Get a real-time feed of all STRATEC SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for STRATEC SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for STRATEC SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-03-17 | Wolfinger, Marcus | Board | Buy | None | 10,125.00 EUR |
| 2023-03-15 | Büchsner, Dr. Michael | Board | Buy | None | 29,380.00 EUR |
| 2023-03-15 | Wolfinger, Marcus | Board | Buy | None | 10,077.50 EUR |
| 2023-03-14 | Büchsner, Dr. Michael | Board | Buy | None | 29,680.00 EUR |
| 2023-03-13 | Wolfinger, Marcus | Board | Buy | None | 14,652.00 EUR |
| 2023-03-10 | Heni, Prof. Dr. Georg | Supervisory board | Buy | None | 27,000.00 EUR |
| 2023-03-10 | Wolfinger, Marcus | Board | Buy | None | 13,740.00 EUR |
| 2022-11-16 | Wolfinger, Marcus | Board | Other | None | 317,065.00 EUR |
| 2022-11-16 | Wolfinger, Marcus | Board | Other | None | 282,500.00 EUR |
| 2022-11-16 | Siegle, Dr. Robert | Board | Other | None | 181,180.00 EUR |
Peer Companies
